CAPTRUST FINANCIAL ADVISORS - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,0000.0%1,994
+31.9%
0.00%
Q1 2022$4,0000.0%1,512
+83.1%
0.00%
Q4 2021$4,0000.0%8260.0%0.00%
Q3 2021$4,000
-33.3%
8260.0%0.00%
Q2 2021$6,0000.0%8260.0%0.00%
Q1 2021$6,000
+20.0%
826
+3.2%
0.00%
Q4 2020$5,000
+25.0%
8000.0%0.00%
Q3 2020$4,0000.0%8000.0%0.00%
Q2 2020$4,0008000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders